BI Asset Management Fondsmaeglerselskab A S Makes New Investment in Astera Labs, Inc. $ALAB

BI Asset Management Fondsmaeglerselskab A S bought a new position in Astera Labs, Inc. (NASDAQ:ALAB) during the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 9,720 shares of the company’s stock, valued at approximately $1,065,000.

A number of other large investors have also made changes to their positions in ALAB. Royal Bank of Canada lifted its holdings in shares of Astera Labs by 167.3% in the first quarter. Royal Bank of Canada now owns 152,453 shares of the company’s stock valued at $9,097,000 after purchasing an additional 95,409 shares in the last quarter. AQR Capital Management LLC lifted its stake in Astera Labs by 213.4% in the 1st quarter. AQR Capital Management LLC now owns 11,391 shares of the company’s stock worth $680,000 after acquiring an additional 7,756 shares in the last quarter. Empowered Funds LLC boosted its position in Astera Labs by 917.3% during the 1st quarter. Empowered Funds LLC now owns 4,639 shares of the company’s stock worth $277,000 after acquiring an additional 4,183 shares during the period. First Trust Advisors LP boosted its position in Astera Labs by 102.0% during the 2nd quarter. First Trust Advisors LP now owns 112,766 shares of the company’s stock worth $10,196,000 after acquiring an additional 56,952 shares during the period. Finally, Brown Advisory Inc. grew its stake in Astera Labs by 54.9% during the 2nd quarter. Brown Advisory Inc. now owns 5,581 shares of the company’s stock valued at $505,000 after acquiring an additional 1,977 shares in the last quarter. Institutional investors and hedge funds own 60.47% of the company’s stock.

Analyst Ratings Changes

ALAB has been the subject of several research reports. Needham & Company LLC raised their price target on shares of Astera Labs from $220.00 to $260.00 and gave the stock a “buy” rating in a report on Wednesday, May 6th. Bank of America increased their target price on shares of Astera Labs from $240.00 to $450.00 and gave the stock a “neutral” rating in a research report on Tuesday. Evercore reissued an “outperform” rating and set a $297.00 target price on shares of Astera Labs in a research note on Tuesday, May 19th. Morgan Stanley boosted their price target on shares of Astera Labs from $210.00 to $240.00 and gave the company an “overweight” rating in a report on Wednesday, May 6th. Finally, Barclays upped their price target on shares of Astera Labs from $165.00 to $200.00 and gave the stock an “equal weight” rating in a research note on Thursday, May 7th. Twelve analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the stock. According to data from MarketBeat.com, Astera Labs currently has an average rating of “Moderate Buy” and an average target price of $254.75.

Astera Labs Price Performance

NASDAQ ALAB opened at $399.92 on Thursday. Astera Labs, Inc. has a fifty-two week low of $84.78 and a fifty-two week high of $440.99. The stock’s 50-day moving average is $280.26 and its two-hundred day moving average is $193.05. The firm has a market cap of $68.55 billion, a P/E ratio of 270.22, a price-to-earnings-growth ratio of 5.26 and a beta of 3.95.

Astera Labs (NASDAQ:ALAB) last released its quarterly earnings results on Tuesday, May 5th. The company reported $0.61 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.54 by $0.07. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.The company had revenue of $308.36 million during the quarter, compared to the consensus estimate of $292.19 million. During the same quarter in the prior year, the company posted $0.33 EPS. The firm’s revenue was up 93.5% on a year-over-year basis. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. On average, equities analysts expect that Astera Labs, Inc. will post 1.84 EPS for the current year.

Insider Buying and Selling at Astera Labs

In related news, CEO Jitendra Mohan sold 325,693 shares of the company’s stock in a transaction on Friday, April 17th. The shares were sold at an average price of $172.14, for a total transaction of $56,064,793.02. Following the completion of the sale, the chief executive officer directly owned 4,079,322 shares of the company’s stock, valued at approximately $702,214,489.08. This represents a 7.39% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, COO Sanjay Gajendra sold 400,000 shares of the company’s stock in a transaction on Thursday, May 21st. The stock was sold at an average price of $290.30, for a total transaction of $116,120,000.00. Following the sale, the chief operating officer directly owned 5,064,213 shares of the company’s stock, valued at approximately $1,470,141,033.90. This represents a 7.32% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 2,161,256 shares of company stock worth $459,844,296 over the last 90 days. Insiders own 10.40% of the company’s stock.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.